The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-60844-9
Affiliations:
4
Authors:
10
Go to article
Institutions Authors Share
Medical University of Graz (Med Uni Graz), Austria
7.000000
 0.70
University Medical Center Utrecht (UMC Utrecht), Netherlands
1.500000
 0.15
BioTechMed-Graz, Austria
1.000000
 0.10
Cleara Biotech, Netherlands
0.500000
 0.05
Interested in Oncology and Carcinogenesis?